Back to article: Fecal gelatinase does not predict mortality in patients with alcohol-associated hepatitis


FIGURE 1: Fecal gelatinase does not predict 30-day or 90-day mortality in patients with alcohol-associated hepatitis. (A) Kaplan-Meier curve for 30-day survival in gelatinase positive and gelatinase negative patients with alcohol-associated hepatitis. (B) Kaplan-Meier curve for 90-day survival in gelatinase positive and gelatinase negative patients with alcohol-associated hepatitis. (C) ROC curves of liver disease markers for 30-day mortality in patients with alcohol-associated hepatitis. (D) ROC curves of liver disease markers for 90-day mortality in patients with alcohol-associated hepatitis (Gelatinase n=60, Child-Pugh n=57, FIB-4 n=57, Maddrey’s DF n=52, ABIC n=59, MELD score n=59, and MELD-Na score n=59). ABIC, ‘Age, serum bilirubin, INR, and serum creatinine score’; FIB-4, Fibrosis-4 Index; INR, international normalized ratio; Maddrey’s DF, Maddrey’s Discriminant Function; MELD, model for end-stage liver disease; MELD-Na, sodium-adjusted model for end-stage liver disease; ROC, receiver operating characteristic.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.

Close